Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes

Patients on haemodialysis (HD-patients) have an increased risk of premature death. Low levels of IgM antibodies against malondialdehyde (anti-MDA) are associated with increased risk of cardiovascular disease (CVD) with underlying potential mechanisms described. Here, we studied subclasses and isotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Samal, Shailesh Kumar, Qureshi, Abdul Rashid, Rahman, Mizanur, Stenvinkel, Peter, Frostegård, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141181/
https://www.ncbi.nlm.nih.gov/pubmed/32168733
http://dx.doi.org/10.3390/jcm9030753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141181/
https://www.ncbi.nlm.nih.gov/pubmed/32168733
http://dx.doi.org/10.3390/jcm9030753

Ejemplares similares